Horizon Kinetics Medical ETF (NASDAQ:MEDX) Sees Significant Decline in Short Interest

Horizon Kinetics Medical ETF (NASDAQ:MEDX) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totaling 188 shares, a decrease of 84.1% from the December 31st total of 1,180 shares. Based on an average daily volume of 777 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 777 shares, the short-interest ratio is currently 0.2 days.

Horizon Kinetics Medical ETF Stock Up 0.5%

MEDX traded up $0.18 during trading hours on Thursday, hitting $33.57. The stock had a trading volume of 211 shares, compared to its average volume of 2,501. The stock has a market cap of $19.14 million, a PE ratio of 19.02 and a beta of 0.62. Horizon Kinetics Medical ETF has a 1 year low of $23.46 and a 1 year high of $34.29. The company’s fifty day simple moving average is $33.48 and its 200 day simple moving average is $31.05.

Horizon Kinetics Medical ETF Announces Dividend

The business also recently declared an annual dividend, which was paid on Wednesday, December 24th. Stockholders of record on Tuesday, December 23rd were given a $0.4088 dividend. The ex-dividend date was Tuesday, December 23rd. This represents a dividend yield of 122.0%.

About Horizon Kinetics Medical ETF

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.